News
Attruby, a near complete TTR stabilizer (≥90%), approved by FDA to reduce cardiovascular death...
The U.S. Food and Drug Administration (FDA) has approved BridgeBio Pharma's Attruby (acoramidis), an orally-administered near-complete (≥90%) stabilizer of Transthyretin (TTR) for the treatment...
Arexvy approval expanded to adults aged 50-59 at increased risk of severe RSV disease...
Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved a regulatory application to extend the indication of GSK's Arexvy (respiratory syncytial virus vaccine,...
Northern Gritstone leads £4m Seed investment into single-molecule platform company Exciting Instruments
Northern Gritstone has led a £4 million Seed investment into the University of Sheffield spinout, Exciting Instruments, the single-molecule platform company.
Single-molecule microscopy is one...
